GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Charmacy Pharmaceutical Co Ltd (HKSE:02289) » Definitions » Future 3-5Y Total Revenue Growth Rate

Charmacy Pharmaceutical Co (HKSE:02289) Future 3-5Y Total Revenue Growth Rate : N/A (As of May. 30, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Charmacy Pharmaceutical Co Future 3-5Y Total Revenue Growth Rate?

Future 3-5Y Total Revenue Growth Rate is the average growth rate of total revenue estimates over a 3-year to 5-year period.

As of today, Charmacy Pharmaceutical Co's Future 3-5Y Total Revenue Growth Rate is N/A.


Competitive Comparison of Charmacy Pharmaceutical Co's Future 3-5Y Total Revenue Growth Rate

For the Medical Distribution subindustry, Charmacy Pharmaceutical Co's Future 3-5Y Total Revenue Growth Rate, along with its competitors' market caps and Future 3-5Y Total Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Charmacy Pharmaceutical Co's Future 3-5Y Total Revenue Growth Rate Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Charmacy Pharmaceutical Co's Future 3-5Y Total Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Charmacy Pharmaceutical Co's Future 3-5Y Total Revenue Growth Rate falls into.


;
;

Charmacy Pharmaceutical Co  (HKSE:02289) Future 3-5Y Total Revenue Growth Rate Explanation

Future 3-5Y Total Revenue Growth Rate is the growth rate of total revenue estimates over a 3-year to 5-year period. This data is provided directly by our trusted data vendors Refinitiv or Morningstar.

In situations where both vendors do not directly provide the growth rate data, we use the most recent annual revenue for the current year and estimated future revenue figures provided by the vendor to calculate the growth rate. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average total revenue estimates growth rate.


Charmacy Pharmaceutical Co Future 3-5Y Total Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Charmacy Pharmaceutical Co's Future 3-5Y Total Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Charmacy Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 235, Song Shan North Road, Longhu District, Guangdong Province, Shantou, CHN, 515041
Charmacy Pharmaceutical Co Ltd is a China-based pharmaceutical distributor. It distributes Western medicine, Chinese patent medicine, and healthcare products to downstream distributors and retail terminals while conducting dealings in the third-party logistics business of medicines and providing pharmaceutical products-related consulting services. The company's distribution network covers Southern China and surrounding areas including Fujian province. All the group's operations are located in China.
Executives
Jiangxi Pharmaceutical Investment Co., Limited 2101 Beneficial owner
Jiang Yao Ji Tuan You Xian Gong Si 2201 Interest of corporation controlled by you
Jiang Xi Jiang Zhong Yi Yao Shang Ye Yun Ying You Xian Ze Ren Gong Si 2201 Interest of corporation controlled by you
Yao Chuanglong 2101 Beneficial owner
You Zeyan 2202 Interest of your spouse
Guang Zhou Bai Yun Shan Yi Yao Ji Tuan Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Guang Zhou Yi Yao Ji Tuan You Xian Gong Si 2201 Interest of corporation controlled by you
Guang Yao Bai Yun Shan Xiang Gang You Xian Gong Si 2101 Beneficial owner
Rays Capital Partners Limited 2102 Investment manager
Ruan David Ching Chi 2201 Interest of corporation controlled by you
Asian Equity Special Opportunities Portfolio Master Fund Limited 2101 Beneficial owner
Wang Yonghui 2101 Beneficial owner

Charmacy Pharmaceutical Co Headlines

No Headlines